Form 4: Health Catalyst Executive Linda Llewelyn Sells Shares Under 10b5-1 Trading Plan

Linda Llewelyn, Chief People Officer of Health Catalyst, Inc., sold 1,290 shares of common stock at $6.51 per share on July 15, 2024, under a pre-arranged trading plan.

Summary

• On July 15, 2024, Linda Llewelyn, the Chief People Officer of Health Catalyst, Inc. (HCAT), sold 1,290 shares of the company's common stock.
• The sale was executed at a price of $6.51 per share.
• This transaction was conducted under a pre-arranged written trading plan adopted on May 23, 2023, in accordance with Rule 10b5-1.
• Following the reported transaction, Llewelyn still beneficially owns 119,864 shares of Health Catalyst common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reports a routine stock sale under a pre-arranged trading plan. It doesn't inherently indicate positive or negative sentiment towards the company's prospects.

Industry Context

Insider sales are a common occurrence, and the use of 10b5-1 plans allows insiders to sell shares without being accused of trading on material non-public information. The market will likely interpret this sale in the context of the company's overall performance and the executive's remaining holdings.

Stakeholder Impact

• The sale of shares by a company executive could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates concerns about insider trading.

Key Dates